[A trial of cronassial use in late postpoliomyelitis syndrome].
The results are presented of treatment with gangliosides (Cronassial) in 5 patients with late postpoliomyelitis syndrome. Clinical and electrophysiological examination were done before and after three months of treatment. Only subjective improvement was found. A year-long follow-up failed to fluid progression of the signs and symptoms that, formerly, were progressing slowly. It seems that Cronassial administration (in larger doses and for a longer time) is justified in patients with peripheral motor neuron lesion.
Hausmanowa-Petrusewicz
I
I
Kliniki Neurologicznej AM i Zespołu Badawczego Chorób Nerwowo-Mieśniowych CMDiK PAN, Warszawie.
Emeryk
B
B
Rowińska
K
K
D000328:Adult; D004576:Electromyography; D005260:Female; D005500:Follow-Up Studies; D005732:Gangliosides / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D016262:Postpoliomyelitis Syndrome / Q000175:diagnosis / Q000188:drug therapy*
D005732:Gangliosides; C037470:cronassial
Próba stosowania Cronassialu w późnym zespole postpolio.